Amwill Health Care Ltd544353Corporate

Latest results: Mar 2026 4 quarters of data

—

MCap —

Live price not available

Amwill Health Care Ltd — Stock analysis & AI research Amwill Health Care Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹24 Cr

Sales · Mar 2026

+41.2% YoY

₹9 Cr

Operating Profit · Mar 2026

+200.0% YoY

37.5%

OPM % · Mar 2026

+113.1% YoY

₹8 Cr

Net Profit · Mar 2026

+100.0% YoY

₹3.77

EPS · Mar 2026

+79.5% YoY

📝 Amwill Health Care Ltd — results explained

Quarter ended March 2026 (Q4 FY26)

Amwill Health Care Ltd reported revenue of ₹24 crore for the quarter ended March 2026 (Q4 FY26), up 41.2% from ₹17 crore in the same quarter last year.

Net profit rose 100.0% year-on-year to ₹8 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹3.77.

Operating profit stood at ₹9 crore — an operating margin (OPM) of 37.5%, compared with 17.6% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹45 crore with a net profit of ₹12 crore.

Shareholding pattern

As of Mar 2026, promoters held 70.65%, foreign institutional investors (FIIs) 0.00%, public shareholders 29.35% of Amwill Health Care Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

N/A

Current Price ?

N/A

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹45 Cr

OPM ?

28.9%

Profit after tax (TTM) ?

₹12 Cr

EPS (TTM) ?

₹5.70

ROCE ?

21.0%

ROE ?

14.8%

ROA ?

13.8%

Growth

Sales — latest qtr ?

₹24 Cr

PAT — latest qtr ?

₹8 Cr

YoY qtr sales growth ?

41.2%

YoY qtr profit growth ?

100.0%

Sales growth (3y) ?

17%

Sales growth (5y) ?

21%

Profit growth (3y) ?

54%

Profit growth (5y) ?

68%

Financial Health

Debt ?

₹0 Cr

Debt to Equity ?

0.00

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

70.65%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

N/A

Return 6 months ?

N/A

🗓️ Quarterly results (4 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Sep 2024	Mar 2025	Sep 2025	Mar 2026	YoY %	QoQ %
Sales	23	17	21	24	+41.2%	—
Operating Profit	9	3	4	9	+200.0%	—
Other Income	0	1	1	2	+100.0%	—
Interest	0	0	0	0	—	—
Depreciation	0	0	0	0	—	—
Profit Before Tax	9	3	5	10	+233.3%	—
Net Profit	7	4	4	8	+100.0%	—
EPS	4.18	2.10	1.93	3.77	+79.5%	—
OPM %	39.1%	17.6%	19.0%	37.5%	+113.1%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
CWIP	-0	1	0	-0	—
Equity Capital	0.03	0.05	20	20	+0.0%
Reserves	5	17	49	61	+24.5%
Borrowings	0	-0	-0	-0	—
Other Liabilities	8	2	2	6	+200.0%
Total Liabilities	12	19	71	87	+22.5%
Fixed Assets	1	1	1	1	+0.0%
Investments	-0	-0	-0	3	—
Other Assets	12	18	70	83	+18.6%
Total Assets	12	19	71	87	+22.5%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	5	-3	6	8	+33.3%
Cash from Investing Activity	-1	-1	-46	6	+113.0%
Cash from Financing Activity	-0	-0	41	-0	-100.0%
Net Cash Flow	3	-4	1	14	+1300.0%
Free Cash Flow	4	-4	5	7	+40.0%
CFO/OP	135%	6%	62%	88%	+41.9%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	16	114	163	168	+3.1%
Inventory Days	—	66	—	22	—
Days Payable	—	39	—	66	—
Cash Conversion Cycle	16	141	163	124	-23.9%
Working Capital Days	-38	111	166	150	-9.6%
ROCE %	133%	153%	28%	21%	-25.0%

👥 Shareholding (latest 3 periods)

Metric	Mar 2025	Sep 2025	Mar 2026	% Chg
Promoters	70.65%	70.65%	70.65%	+0.0%
FIIs	1.16%	1.16%	0.00%	-100.0%
Public	28.19%	28.20%	29.35%	+4.1%
No. of Shareholders	1,374	1,606	1,483	-7.7%

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.

❓ Frequently asked questions

What was Amwill Health Care Ltd's revenue in Q4 FY26?